China releases powerful DNA-screening AI tool for free to help fight rare diseases
Summary
Chinese researchers at BGI-Research released OneGenome, an open-source AI system that interprets gene mutations for clinical diagnosis, outperforming general LLMs like DeepSeek-v4, to help shorten the diagnostic odyssey for rare disease patients.
View Cached Full Text
Cached at: 08/11/26, 03:29 AM
Similar Articles
Google’s Atlas of the human genome could pave the way for new treatments
Google DeepMind releases AlphaGenome Atlas, an AI tool that provides predictive maps of all possible DNA variations in the human genome to accelerate disease research.
Applying technology to understand and treat disease (1 minute read)
Google 聚合其五年来在医疗健康领域的研究成果,涵盖 AlphaGenome Atlas、AlphaFold 药物筛选、脑科学纳米级重建等,展示了 AI 如何加速疾病检测、治疗与预防。
AlphaGenome: AI for better understanding the genome
DeepMind introduces AlphaGenome, an AI model that predicts how DNA sequence variants impact gene regulation and biological processes across diverse cell types and tissues. The model processes up to 1 million base pairs and is available via API for non-commercial research, with the full paper published in Nature.
Using AI to help physicians diagnose rare genetic diseases affecting children
Researchers from Boston Children's Hospital, Harvard, and OpenAI used the OpenAI o3 Deep Research reasoning model to reanalyze 376 unsolved rare disease cases, leading to diagnoses in 18 additional cases (4.8% yield) after expert review and clinical confirmation. The study, published in NEJM AI, demonstrates how AI-assisted workflows can help experts revisit difficult cases as scientific knowledge evolves.
You know AlphaFold, which cracked the shapes of 250k proteins from DNA. Now AlphaGenome is 30x bigger with far more capability --- "DeepMind's New AI Just Cracked The Code Of Life"
DeepMind has released AlphaGenome, a machine learning model that predicts the impact of genomic variants at base-pair resolution with a context window of one million base pairs. It matches or outperforms the strongest competing models on 25 of 26 variant effect benchmarks. Accompanied by the AlphaGenome Atlas, which has pre-computed the effects of roughly nine billion single-nucleotide variants — a scale 30 times that of the AlphaFold database — the model weights are permanently free for the scientific community.